Halozyme Therapeutics Pre-Tax Income 2010-2024 | HALO
- Halozyme Therapeutics annual pre-tax income for 2023 was $0.348B, a 39.94% increase from 2022.
- Halozyme Therapeutics annual pre-tax income for 2022 was $0.249B, a 0.16% increase from 2021.
- Halozyme Therapeutics annual pre-tax income for 2021 was $0.249B, a 92.2% increase from 2020.